The cetuximab experience: developing predictive biomarkers in oncology

Author： Harbison Christopher T Horak Christine E Khambata-Ford Shirin

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.2, 2011-03, pp. : 149-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

By Simon Richard

Personalized Medicine, Vol. 7, Iss. 1, 2010-01 ,pp. : 33-47

Future Medicine

Access to resources Recommend Favorite

Clinical Biomarkers in Oncology: Focus on Colorectal Cancer

By > Biesmans Bart > Tejpar Sabine

Molecular Diagnosis & Therapy, Vol. 13, Iss. 2, 2009-04 ,pp. : 103-114

Adis International

Access to resources Recommend Favorite

Predictive medicine and biomarkers: the case of rare diseases

By Taruscio Domenica Salvatore Marco Magrelli Armando Tomanin Rosella

Personalized Medicine, Vol. 9, Iss. 2, 2012-03 ,pp. : 143-146

Future Medicine

Access to resources Recommend Favorite

Preliminary Experience of Cetuximab in the Treatment of Advanced-Stage Biliary Tract Cancer

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

A development framework for the consultant radiographer in oncology: the Leeds experience

Journal of Radiotherapy in Practice, Vol. 15, Iss. 2, 2016-03 ,pp. : 210-214

Cambridge University Press

Access to resources Recommend Favorite